Ameliorative potential of montelukast on ischemia-reperfusion injury induced vasculitic neuropathic pain in rat

详细信息	查看全文 | 推荐本文 |

• 作者：Arunachalam Muthuraman^a ; ^b ; ^{arunachalammu@gmail.com} ; Muthusamy Ramesh^c ; Shailja Sood^b
• 关键词：Leukotriene ; Montelukast ; Myeloperoxidase ; Neuropathic pain ; Total calcium ; Vascular Injury
• 刊名：Life Sciences
• 出版年：2012
• 期刊代码：62_00243205
• 类别：imm
• 出版时间：22 May, 2012
• 卷：90
• 期：19-20
• 页码：755-762
• 文件大小：917 K

摘要

Aims

Ischemia -reperfusion (I/R) event in vascular and nervous system has been documented to rising ischemic and vasculitic neuropathic pain, clinically resembles the complex regional pain syndrome (CRPS). The present study evaluated the effect of montelukast, a cysteinyl leukotriene receptor (Cys-LTC₄ and Cys-LTD₄) antagonist on ischemia -reperfusion (I/R) induced vasculitic neuropathic pain in rats.

Main Methods

Behavioral parameters were assessed at different time intervals (i.e. 0, 1, 7, 14 and 21st day) and biochemical analysis in sciatic nerve tissue samples were also performed along with histopathological studies.

Key Findings

Behavioral pain assessment has shown increase in paw and tail withdrawal threshold in montelukast treated groups against thermal and mechanical stimuli as compared to I/R control group. We observed a decrease in the total calcium, thiobarbituric acid reactive substance (TBARS) and myeloperoxidase (MPO) activity levels, whereas there is rise in reduced glutathione level in montelukast treated groups as compared to I/R control group. However, significant behavioral and biochemical results were observed only in medium and high dose of treated groups which were comparable to normal control group. Moreover, histopathological study has revealed the reduction of I/R induced neuronal edema and axonal degeneration due to montelukast.

Significance

Montelukast has ameliorated I/R induced vasculitic neuropathic pain, these effects may be due to inhibition of lipid peroxidation, reduction of oxidative stress, release of inflammatory mediators and neuroprotective actions. Hence, it could be used as a novel therapeutic agent for the management of vasculitic inflammation related neuropathic pain.